Literature DB >> 11932687

Retroperitoneoscopic lumbar sympathectomy.

Nahum Beglaibter1, Yacov Berlatzky, Oded Zamir, Ram M Spira, Herbert R Freund.   

Abstract

We present a series of 27 consecutive unselected patients who underwent 29 retroperitoneoscopic lumbar sympathectomies. There were 21 male patients and six female patients, with a mean age of 45 years (RANGE, 21 to 28 years). Twenty-two patients had ischemia of the lower limb, and five patients had severe reflex sympathetic dystrophy. The retroperitoneal space was developed with a balloon trocar inserted through a small incision in the flank. Additional trocars used for endoscopic instruments. The sympathetic chain from the ganglia second lumbar vertebrae to the fourth lumbar vertebrae was resected. The procedure was successfully accomplished in all the patients without any operative or postoperative complications. The mean operative time Was 136 minutes, and the mean hospital stay was 1.4 days. All the patients had significant improvement of pain or dystrophic changes. Retroperitoneoscopic lumbar sympathectomy successfully combines the advantages of minimally invasive surgery with the effectiveness of the open procedure.

Entities:  

Mesh:

Year:  2002        PMID: 11932687     DOI: 10.1067/mva.2002.121130

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Buerger's Disease; Any Current Advances?

Authors:  Yong-Bok Koh
Journal:  Ann Vasc Dis       Date:  2008-10-24

2.  Retroperitoneoscopic lumbar sympathectomy for the treatment of plantar hyperhidrosis: technique and preliminary findings.

Authors:  R Rieger; S Pedevilla
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

3.  Endoscopic lumbar sympathectomy for women: effect on compensatory sweat.

Authors:  Marcelo de Paula Loureiro; José Ribas Milanez de Campos; Paulo Kauffman; Fábio Biscegli Jatene; Sheila Weigmann; Aline Fontana
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.